APA (7th ed.) Citation

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, & ProQuest (Firm). (2005). Importation of prescription drugs: Hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004. U.S. G.P.O..

Chicago Style (17th ed.) Citation

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, and ProQuest (Firm). Importation of Prescription Drugs: Hearing Before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, Second Session, on Examining Prescription Drug Reimportation, Focusing on Efforts to Reduce Drug Costs, Patient Safety Concerns, Recent State Action, Fraudulent and Counterfeit Drugs, an International Comparison of Rising Prescription Drug Expenditures, and S. 2328, to Amend the Federal Food, Drug, and Cosmetic Act with Respect to the Importation of Prescription Drugs, May 20, 2004. Washington: U.S. G.P.O., 2005.

MLA (9th ed.) Citation

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, and ProQuest (Firm). Importation of Prescription Drugs: Hearing Before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, Second Session, on Examining Prescription Drug Reimportation, Focusing on Efforts to Reduce Drug Costs, Patient Safety Concerns, Recent State Action, Fraudulent and Counterfeit Drugs, an International Comparison of Rising Prescription Drug Expenditures, and S. 2328, to Amend the Federal Food, Drug, and Cosmetic Act with Respect to the Importation of Prescription Drugs, May 20, 2004. U.S. G.P.O., 2005.